GL1X · GenesisL1 explorer

MolNFT v1 · #166950 · protein

Inhibitory scaffolding of the ancient MAPK, ERK7

6V6A · Mitogen-activated protein kinase: “Inhibitory scaffolding of the ancient MAPK, ERK7”. X-ray diffraction, 8 pockets (best druggability 0.72). MolNFT v1 #166950 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6V6A
Type
protein
Length
682 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase; Apical cap protein 9 (AC9)
EC
2.7.11.24
UniProt
Q2QDG8, S7V0W9
Pockets
8 · best druggability 0.72

Structure

x-ray diffraction · 3 distinct chains · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase (EC 2.7.11.24)protein31744% helix, 15% strandQ2QDG8
B, DApical cap protein 9 (AC9)protein3321% helix, 0% strandS7V0W9
CMitogen-activated protein kinase (EC 2.7.11.24)protein29941% helix, 16% strandQ2QDG8

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 5 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17820.720.7873empty
22880.620.8040empty
3870.490.8219EDO
4620.440.8213empty
5530.340.7814EDO

Interfaces

6 interfaces between chains.

  • A–B · 1754 Ų buried · 28 hydrogen bonds · protein-protein
  • C–D · 1701 Ų buried · 23 hydrogen bonds · protein-protein
  • A–C · 203 Ų buried · 3 hydrogen bonds · protein-protein
  • B–D · 90 Ų buried · 0 hydrogen bonds · protein-protein
  • A–D · 78 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 6V6A · Inhibitory scaffolding of the ancient MAPK, ERK7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.